CU Anschutz Newsroom

A chemical sunscreen available in Europe and Asia for decades is coming to U.S. beaches, pools, barbecues and anywhere people enjoy the outdoors. The U.S. Food and Drug Administration’s (FDA) June 9 approval of bemotrizinol “is a really big deal” and will offer more robust skin protection for consumers, says a CU Anschutz dermatologist.

medicinenutritionpublic-health

Researchers at the University of Colorado Anschutz have published a proof-of-concept study in Fertility and Sterility demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome (PMOS), f ormerly known as polycystic ovary syndrome (PCOS).

medicinepharmacologyreproductive-health

When asked if she could walk unassisted after taking part in a clinical trial, Lynn Montgomery-Haga jumps up from her chair and does a quick lap around the tables of her small town’s only coffee shop. At the end, the longtime Milliken, Colo., resident throws her arms in the air, taking a “ta-da!”-like pose. The answer was a definite yes.

gene-therapymedicinereproductive-health

In each cell of your body, DNA is stored in structures called chromosomes. When cells divide, these chromosomes are copied, but over time, the copying process degrades. After many cycles of making copies, the ends of the chromosomes become shorter and can sometimes get damaged. Thankfully, we have telomeres, which are like protective caps on the ends of our chromosomes that help to decrease the d…

The Takeaway: A retrospective review of more than 7,300 midwife attended births in three Colorado hospitals found that labor induction did not increase the likelihood of cesarean birth compared to expectant management. Researchers from the CU Anschutz College of Nursing found that prolonged pregnancy beyond 41 weeks – not induction itself – was associated with higher C-section rates. The study al…

medicinereproductive-health
Christopher.Casey@ucdenver.edu (Chris Casey)
13d ago

In the month following a psychiatric discharge after an attempted suicide, a person is up to 300 times more likely to make another attempt than the general population. The risk is highest in the first hours and days – when the individual is often overwhelmed or hopeless.

medicinepsychiatrypublic-health

Five years after the start of the COVID 19 pandemic, many people still say they feel more anxious, emotionally exhausted or socially disconnected than they did before 2020. Researchers at the University of Colorado Anschutz say these lingering effects may be tied to prolonged pandemic stress, a form of chronic uncontrollable stress that can reshape both brain and immune system function over time.

cognitive-psychologyneuroimagingneurosciencepsychology

Welcome to Science Snapshot , a quick digest of the latest research happening across the CU Anschutz campus. Hear from researchers as they briefly explain one of their recent studies and how it could improve healthcare. This installment explores the effects of acid reflux medications on the gut microbiome and whether standard use of component blood tranfusions in trauma settings is better than us…

biologymedicinemicrobiologypharmacology

The Takeaway: A CU Anschutz-led study suggests acetaminophen may relieve pain by interacting with the body’s endocannabinoid system, which regulates pain and inflammation. In knee replacement patients, changes in cannabis-like molecules were linked to both acetaminophen use and reported pain levels. These findings could inform more targeted pain therapies in the future. Despite acetaminophen’s po…

medicinepain-reliefpharmacology
matthew.hastings@ucdenver.edu (Matthew Hastings)
26d ago

The takeaway: A group of four faculty presenters detail the work behind their startups at a Fast Pitch event for a $10,000 award: mindLAMP Care, Retro Nephrix, NeuroVesica, Parley Neurotech. The CU Anschutz Innovations event provides a window into how ideas move from the lab to improving health for patients. How would you convince a room of strangers you had the next great idea in healthcare in u…

The takeaway: Orforglipron is an FDA-approved non-peptide oral GLP-1 pill, offering a potential alternative to injectable weight-loss drugs. Demand for GLP-1 medications has surged in recent years, but cost and injectable delivery have limited access for many patients. A CU Anschutz researcher is overseeing a clinical trial for orforglipron, and a patient shares her experience in the trial. Every…

clinical-trialsmedicinepharmacology
debra.melani@cuanschutz.edu (Debra Melani)
5/15/2026

Thomas Delong , PhD, moved to Colorado from Germany two decades ago intent on one thing: understanding the origin of type 1 diabetes (T1D) and finding ways to stop it. Diagnosed at age 12 with the disease that affects 9.5 million people worldwide, Delong’s mission was deep-rooted and personal.

diabetesendocrinologymedicinepublic-health

For 14 years, Grace Hamilton lived with an undiagnosed disease that left her feeling frustrated and alone. Misunderstanding from other kids marked her youth, along with subtle disappointment from her parents, who had no idea that her climbing weight and fluctuating emotions were largely disease driven.

endocrinologymedicinepublic-healthreproductive-health
kelsea.pieters@cuanschutz.edu (Kelsea Pieters)
5/12/2026

Polycystic ovary syndrome (PCOS), a condition affecting more than 170 million people worldwide, has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a landmark global consensus study published today in The Lancet .

infectious-diseasemedicinepublic-health
research.ioresearch.io

Sign up to keep scrolling

Create your feed subscriptions, save articles, keep scrolling.

Already have an account?